Share
The key list
Powered by
Leading emerging companies in Europe by R&D Expenditure
This month our power industry key list brings you the 15 largest emerging companies in Europe by R&D Expenditure, as ranked by GlobalData's Power Intelligence Centre. All numbers as of April 2020.
| Company name | Annual R&D Expenditure ($million) | Headquarters location | Number of employees |
F. Hoffmann-La Roche Ltd | 11,294 | Switzerland | 97,735 |
Novartis AG | 8,681 | Switzerland | 103,914 |
Sanofi | 6,951 | France | 104,226 |
Bayer AG | 6,191 | Germany | 104,711 |
AstraZeneca Plc | 5,266 | UK | 70,600 |
GlaxoSmithKline Plc | 4,969 | UK | 99,437 |
Merck KGaA | 2,621 | Germany | 52,140 |
Allergan Plc | 2,266 | Ireland | 17,400 |
Novo Nordisk AS | 2,148 | Denmark | 43,258 |
UCB SA | 1,370 | Belgium | 7,495 |
Mylan NV | 569 | UK | 35,000 |
H. Lundbeck AS | 501 | Denmark | 5,569 |
Alkermes Plc | 425 | Ireland | 2,300 |
Galapagos NV | 381 | Belgium | 725 |
Idorsia Pharmaceutical Ltd | 378 | Switzerland | 636 |
Share this article
